Munich Reinsurance Co Stock Corp in Munich Decreases Stock Holdings in HCA Healthcare, Inc. $HCA

Munich Reinsurance Co Stock Corp in Munich cut its position in HCA Healthcare, Inc. (NYSE:HCA) by 9.8% in the first quarter, HoldingsChannel.com reports. The firm owned 21,866 shares of the company’s stock after selling 2,379 shares during the period. Munich Reinsurance Co Stock Corp in Munich’s holdings in HCA Healthcare were worth $10,348,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at $26,000. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare in the fourth quarter worth about $29,000. Ares Financial Consulting LLC acquired a new position in shares of HCA Healthcare during the fourth quarter valued at about $31,000. JPL Wealth Management LLC acquired a new stake in HCA Healthcare in the 3rd quarter worth approximately $33,000. Finally, Aventura Private Wealth LLC acquired a new position in HCA Healthcare during the 4th quarter valued at approximately $34,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on HCA shares. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Sanford C. Bernstein cut their price objective on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a report on Thursday, June 4th. Robert W. Baird decreased their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Wells Fargo & Company reduced their price target on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research report on Monday, April 27th. Finally, Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $497.14.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Negative Sentiment: Barclays reaffirmed its equal weight rating but lowered its price target sharply to $427 from $496, signaling reduced expectations for HCA Healthcare’s near-term stock performance. Benzinga
• Negative Sentiment: Cantor Fitzgerald cut its price target on HCA Healthcare to $525 from $588, reflecting a more cautious stance even while keeping an overweight rating. Benzinga
• Neutral Sentiment: Options-market activity is drawing attention because traders appear to be positioning for a larger move in HCA Healthcare stock, but the headline does not confirm a clear directional catalyst. Zacks
• Neutral Sentiment: Commentary around HCA’s post-earnings valuation and hold/buy-sell debate adds uncertainty, but it mainly reinforces that investors are reassessing the stock after recent results. MSN
• Positive Sentiment: Longer-term bullish pieces highlight HCA Healthcare’s capacity-expansion strategy, ongoing revenue and profit growth, and sizable buyback capacity, which support the investment case over time. Zacks
• Positive Sentiment: Seeking Alpha argued that HCA remains attractively priced despite recent underperformance, citing improving fundamentals, rising revenue and profitability, and ongoing shareholder returns. Seeking Alpha

HCA Healthcare Trading Down 3.1%

Shares of HCA stock opened at $409.98 on Thursday. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The stock has a 50 day moving average of $398.58 and a 200 day moving average of $461.22. The stock has a market cap of $90.95 billion, a P/E ratio of 14.10, a P/E/G ratio of 1.34 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the business earned $6.45 EPS. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.